Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Gross Profit (2020 - 2025)

Historic Gross Profit for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $5.2 million.

  • Maxcyte's Gross Profit fell 1608.4% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 2979.49%. This contributed to the annual value of $31.5 million for FY2024, which is 1373.34% down from last year.
  • According to the latest figures from Q3 2025, Maxcyte's Gross Profit is $5.2 million, which was down 1608.4% from $7.0 million recorded in Q2 2025.
  • Maxcyte's 5-year Gross Profit high stood at $14.1 million for Q4 2023, and its period low was $5.2 million during Q3 2025.
  • Over the past 5 years, Maxcyte's median Gross Profit value was $8.5 million (recorded in 2022), while the average stood at $8.3 million.
  • Per our database at Business Quant, Maxcyte's Gross Profit skyrocketed by 8140.4% in 2022 and then crashed by 5449.9% in 2024.
  • Quarter analysis of 5 years shows Maxcyte's Gross Profit stood at $8.9 million in 2021, then grew by 21.86% to $10.9 million in 2022, then rose by 29.56% to $14.1 million in 2023, then crashed by 54.5% to $6.4 million in 2024, then dropped by 18.39% to $5.2 million in 2025.
  • Its Gross Profit stands at $5.2 million for Q3 2025, versus $7.0 million for Q2 2025 and $8.9 million for Q1 2025.